Reduced functional brain activity response in cognitively intact apolipoprotein E ε4 carriers
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The apolipoprotein E epsilon4 (APOE epsilon4) is the main known genetic risk factor for Alzheimer's disease. Genetic assessments in combination with other diagnostic tools, such as neuroimaging, have the potential to facilitate early diagnosis. In this large-scale functional MRI (fMRI) study, we have contrasted 30 APOE epsilon4 carriers (age range: 49-74 years; 19 females), of which 10 were homozygous for the epsilon4 allele, and 30 non-carriers with regard to brain activity during a semantic categorization task. Test groups were closely matched for sex, age and education. Critically, both groups were cognitively intact and thus symptom-free of Alzheimer's disease. APOE epsilon4 carriers showed reduced task-related responses in the left inferior parietal cortex, and bilaterally in the anterior cingulate region. A dose-related response was observed in the parietal area such that diminution was most pronounced in homozygous compared with heterozygous carriers. In addition, contrasts of processing novel versus familiar items revealed an abnormal response in the right hippocampus in the APOE epsilon4 group, mainly expressed as diminished sensitivity to the relative novelty of stimuli. Collectively, these findings indicate that genetic risk translates into reduced functional brain activity, in regions pertinent to Alzheimer's disease, well before alterations can be detected at the behavioural level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Priming and Human Memory Systems
Tulving, E., & Schacter, D. L. (1990) · Science · doi:10.1126/science.2296719 · Cited by 2,595
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 2×
“…response was observed in the parietal cortex such that homozygous carriers of the risk allele exhibited greater reduction than heterozy- gous carriers, which strengthens the association between reduced activity in this brain region and risk for Alzheimer’s disease (Corder et al., 1993, 1994).”
BackgroundReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366 · cited 3×
“Previous studies with PET and functional MRI (fMRI) have indicated alterations in glucose metabolism (Small et al., 1995, 2000; Reiman et al., 1996, 2004) and task-related brain activation patterns (Smith et al., 1999; Bookheimer et al., 2000) in APOE «4 carriers, well before the diagnosis of…”
ResultPatterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328 · cited 8×
“…with PET and functional MRI (fMRI) have indicated alterations in glucose metabolism (Small et al., 1995, 2000; Reiman et al., 1996, 2004) and task-related brain activation patterns (Smith et al., 1999; Bookheimer et al., 2000) in APOE «4 carriers, well before the diagnosis of Alzheimer’s disease.”
BackgroundResultInfluentialHariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045 · cited 6×
“In keeping with related work (Hariri et al., 2003) we compared processing of novel versus familiar items to reveal differential activation of the hippocampal region.”
BackgroundMethodInfluentialFunctional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · cited 4×
“Previous studies with PET and functional MRI (fMRI) have indicated alterations in glucose metabolism (Small et al., 1995, 2000; Reiman et al., 1996, 2004) and task-related brain activation patterns (Smith et al., 1999; Bookheimer et al., 2000) in APOE «4 carriers, well before the diagnosis of…”
BackgroundResultInfluentialCerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · cited 2×
“Previous studies with PET and functional MRI (fMRI) have indicated alterations in glucose metabolism (Small et al., 1995, 2000; Reiman et al., 1996, 2004) and task-related brain activation patterns (Smith et al., 1999; Bookheimer et al., 2000) in APOE «4 carriers, well before the diagnosis of…”
ResultSmall, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532
Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C., & Rossor, M. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05408-3 · Cited by 455
Research works printed but not linked: 51
- Birn RM, Cox RW, Bandettini PA. Detection versus estimation in event-related fMRI: choosing the optimal stimulus timing. Neuroimage2002; 15: 252–64. · DOI · Paper page
- Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology1999; 52: 1861–70. · DOI · Paper page
- Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol2003; 60: 949–56. · DOI · Paper page
- Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry2002; 10: 44–51. · DOI
- Cedazo-Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med2001; 5: 254–66. · DOI · Paper page
- Chan AS, Butters N, Salmon DP, McGuire KA. Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. Psychol Aging1993; 8: 411–9. · doi:10.1037/0882-7974.8.3.411
- Chan AS, Butters N, Salmon DP. The deterioration of semantic networks in patients with Alzheimer's disease: a cross-sectional study. Neuropsychologia1997; 35: 241–8. · DOI
- Cohen RM, Small C, Lalonde F, Friz J, Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology2001; 57: 2223–8. · DOI · Paper page
- Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science1993; 261: 921–3. · DOI · Paper page
- Demb JB, Desmond JE, Wagner AD, Vaidya CJ, Glover GH, Gabrieli JD. Semantic encoding and retrieval in the left inferior prefrontal cortex: a functional MRI study of task difficulty and process specificity. J Neurosci1995; 15: 5870–8. · DOI · Paper page
- den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology2002; 59: 746–8. · DOI · Paper page
- Dolan RJ, Fletcher PC. Dissociating prefrontal and hippocampal function in episodic memory encoding. Nature1997; 388: 582–5. · DOI · Paper page
- Duzel E, Habib R, Rotte M, Guderian S, Tulving E, Heinze HJ. Human hippocampal and parahippocampal activity during visual associative recognition memory for spatial and nonspatial stimulus configurations. J Neurosci2003; 23: 9439–44. · DOI · Paper page
- Elgh E, Larsson A, Eriksson S, Nyberg L. Altered prefrontal brain activity in persons at risk for Alzheimer's disease: an fMRI study. Int Psychogeriatr2003; 15: 121–33. · DOI
- Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM. 3D statistical neuroanatomical models from 305 MRI volumes. In: Proceedings of the IEEE-Nuclear Science Symposium and Medical Imaging Conference, San Francisco (CA); 1993. pp. 1813–7. · DOI · Paper page
- Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–98. · DOI · Paper page
- Frackowiak RS, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain1981; 104: 753–78. · DOI · Paper page
- Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging1999; 15: 365–75. · DOI · Paper page
- Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology2000; 54: S10–5.
- Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, et al. Analysis of fMRI time-series revisited. Neuroimage1995; 2: 45–53. · DOI · Paper page
- Grady CL, Haxby JV, Horwitz B, Gillette J, Salerno JA, Gonzalez-Aviles A, et al. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging1993; 14: 35–44. · DOI
- Grossman M, Robinson K, Bernhardt N, Koenig P. A rule-based categorization deficit in Alzheimer's disease? Brain Cogn2001; 45: 265–76. · doi:10.1006/brcg.2000.1245
- Grossman M, Smith EE, Koenig P, Glosser G, DeVita C, Moore P, et al. The neural basis for categorization in semantic memory. Neuroimage2002; 17: 1549–61. · DOI
- Grossman M, Koenig P, Glosser G, DeVita C, Moore P, Rhee J, et al. Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. Brain2003; 126: 292–311. · DOI · Paper page
- Grundman M, Corey-Bloom J, Thal LJ. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. J Neural Transm Suppl1998; 53: 255–75. · DOI
- Grunwald T, Lehnertz K, Heinze HJ, Helmstaedter C, Elger CE. Verbal novelty detection within the human hippocampus proper. Proc Natl Acad Sci USA1998; 95: 3193–7. · DOI · Paper page
- Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull2003; 65: 259–70. · DOI · Paper page
- Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology1998; 50: 1585–93. · DOI · Paper page
- Kato T, Knopman D, Liu H. Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology2001; 57: 812–6. · DOI · Paper page
- Kiehl KA, Liddle PF, Smith AM, Mendrek A, Forster BB, Hare RD. Neural pathways involved in the processing of concrete and abstract words. Hum Brain Mapp1999; 7: 225–33. · DOI · Paper page
- Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience1995; 67: 65–72. · DOI · Paper page
- Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology2000; 54: S4–9.
- Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia1994; 5: 36–41. · DOI · Paper page
- Nilsson L, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. The Betula Prospective Cohort Study: memory, health, and aging. Aging Neuropsychol Cogn1997; 4: 1–32. · DOI · Paper page
- Nilsson L, Adolfsson R, Backman L, de Frias C, Molander B, Nyberg L. Betula: a prospective cohort study on memory, health and aging. Aging Neuropsychol Cogn2004; 11: 134–48. · DOI · Paper page
- Price JL, Morris JC. Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer's disease. Ann Neurol1999; 45: 358–68. · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA2005; 102: 8299–302. · DOI · Paper page
- Sano M. Current concepts in the prevention of Alzheimer's disease. CNS Spectr2003; 8: 846–53. · DOI
- Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet1993; 342: 710–1. · DOI · Paper page
- Saykin AJ, Johnson SC, Flashman LA, McAllister TW, Sparling M, Darcey TM, et al. Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study. Brain1999; 122: 1963–71. · DOI · Paper page
- Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA2002; 99: 4703–7. · DOI · Paper page
- Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology1999; 53: 1391–6. · DOI · Paper page
- Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology2002; 58: 1197–202. · DOI · Paper page
- Soininen H, Partanen K, Pitkanen A, Hallikainen M, Hanninen T, Helisalmi S, et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology1995; 45: 391–2. · DOI · Paper page
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA1993; 90: 1977–81. · DOI · Paper page
- Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett1997; 236: 21–4. · DOI
- Tulving E, Markowitsch HJ, Kapur S, Habib R, Houle S. Novelty encoding networks in the human brain: positron emission tomography data. Neuroreport1994; 5: 2525–8. · DOI · Paper page
- Wagner AD, Desmond JE, Glover GH, Gabrieli JD. Prefrontal cortex and recognition memory. Functional-MRI evidence for context-dependent retrieval processes. Brain1998; 121: 1985–2002. · DOI · Paper page
- Wagner AD, Koutstaal W, Maril A, Schacter DL, Buckner RL. Task-specific repetition priming in left inferior prefrontal cortex. Cereb Cortex2000; 10: 1176–84. · DOI · Paper page
- Weiss AP, Zalesak M, DeWitt I, Goff D, Kunkel L, Heckers S. Impaired hippocampal function during the detection of novel words in schizophrenia. Biol Psychiatry2004; 55: 668–75. · DOI
- Wenham PR, Newton CR, Price WH. Analysis of apolipoprotein E genotypes by the amplification refractory mutation system. Clin Chem1991; 37: 241–4. · DOI · Paper page
Cited by
Default-mode brain dysfunction in mental disorders: A systematic review
Broyd, S. J., Demanuele, C., Debener, S., Helps, S. K., James, C. J., & Sonuga-Barke, E. J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.09.002 · Cited by 1,675
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies
Tromp, D., Dufour, A., Lithfous, S., Pebayle, T., & Després, O. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.006 · Cited by 390
The Default Mode Network in Healthy Aging and Alzheimer′s Disease
Mevel, K., Chételat, G., Eustache, F., & Desgranges, B. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/535816 · Cited by 302
Longitudinal evidence for diminished frontal cortex function in aging
Nyberg, L., Salami, A., Andersson, M., Eriksson, J., Kalpouzos, G., Kauppi, K., Lind, J., Pudas, S., Persson, J., & Nilsson, L.-G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012651108 · Cited by 290
Self-citationDisease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings, J. L., Doody, R., & Clark, C. (2007) · Neurology · doi:10.1212/01.wnl.0000295996.54210.69 · Cited by 279
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study
Zhao, X., Liu, Y., Wang, X., Liu, B., Xi, Q., Guo, Q., Jiang, H., Jiang, T., & Wang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033540 · Cited by 215
Longitudinal Structure-Function Correlates in Elderly Reveal MTL Dysfunction with Cognitive Decline
Persson, J., Pudas, S., Lind, J., Kauppi, K., Nilsson, L.-G., & Nyberg, L. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr306 · Cited by 173
Self-citationApolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging
Jagust, W. J., Landau, S. M., & Initiative, F. T. A. D. N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-12.2012 · Cited by 162
“In cognitively normal older adults, both increases and decreases in brain activation during cognition have been reported with ApoE4 (Bookheimer et al., 2000; Lind et al., 2006); until recently, such results have been difficult to interpret due to the possibility of concomitant unmeasured A .”
ResultNeurovascular function in Alzheimer's disease patients and experimental models
Nicolakakis, N., & Hamel, E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.43 · Cited by 156
“In these groups, neurovascular coupling is either impaired (Lind et al, 2006) or increased in a compensatory manner as in AD patients, being characterized by a larger response magnitude, and neuronal recruitment to achieve performance at the level of healthy elderly controls (Bookheimer et al,…”
BackgroundThe APOE ɛ4 allele modulates brain white matter integrity in healthy adults
Heise, V, Filippini, N., Ebmeier, K. P., & Mackay, C. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.90 · Cited by 152
Bour, A., Grootendorst, J., Vogel, E., Kelche, C., Dodart, J.-C., Bales, K., Moreau, P.-H., Sullivan, P. M., & Mathis, C. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.008 · Cited by 141
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120
Deeny, S. P., Poeppel, D., Zimmerman, J. B., Roth, S. M., Brandauer, J., Witkowski, S., Hearn, J. W., Ludlow, A. T., Contreras-Vidal, J. L., Brandt, J., et al. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.02.007 · Cited by 107
Altered deactivation in individuals with genetic risk for Alzheimer's disease
Persson, J., Lind, J., Larsson, A., Ingvar, M., Sleegers, K., Van Broeckhoven, C., Adolfsson, R., Nilsson, L.-G., & Nyberg, L. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.026 · Cited by 102
Self-citationGenetics and Functional Imaging: Effects of APOE, BDNF, COMT, and KIBRA in Aging
Papenberg, G., Salami, A., Persson, J., Lindenberger, U., & Bäckman, L. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9279-8 · Cited by 39
“Some studies, however, have reported decreased BOLD activations in ε4 carriers, assumed to reflect pathological disruption (Kauppi et al. 2014; Lind et al. 2006; Pihlajamaki et al. 2010; Xu et al. 2009).”
BackgroundResultSelf-citationO'Dwyer, L., Lamberton, F., Matura, S., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., & Hampel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036024 · Cited by 34
Metadata
- Authors
- Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Bäckman, L., Nilsson, L.-G., Petersson, K. M., & Nyberg, L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-03-14
- Volume
- 129
- Issue
- 5
- Pages
- 1240-1248
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2114300989
- Cited by
- 148
- References
- 13
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.